MARKET

EWTX

EWTX

Edgewise Therapeutics, Inc.
NASDAQ
45.41
-2.94
-6.08%
After Hours: 45.41 0 0.00% 16:53 07/10 EDT
OPEN
48.09
PREV CLOSE
48.35
HIGH
48.14
LOW
43.81
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
48.40
52 WEEK LOW
12.30
MARKET CAP
4.89B
P/E (TTM)
-27.3439
1D
5D
1M
3M
1Y
5Y
1D
Edgewise Therapeutics Price Target Announced at $51.00/Share by Oppenheimer
Dow Jones · 2d ago
Oppenheimer Initiates Coverage On Edgewise Therapeutics with Outperform Rating, Announces Price Target of $51
Benzinga · 2d ago
EDGEWISE THERAPEUTICS INC <EWTX.O>: OPPENHEIMER INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $51
Reuters · 2d ago
Edgewise Therapeutics initiated with an Outperform at Oppenheimer
TipRanks · 3d ago
Edgewise Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones · 5d ago
Guggenheim Maintains Buy on Edgewise Therapeutics, Raises Price Target to $51
Benzinga · 5d ago
Edgewise Therapeutics price target raised to $51 from $41 at Guggenheim
TipRanks · 5d ago
Weekly Report: what happened at EWTX last week (0629-0703)?
Weekly Report · 6d ago
More
About EWTX
Edgewise Therapeutics, Inc. is a muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company’s lead product candidate, sevasemten (EDG-5506), is an orally administered skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. Its EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophic cardiomyopathy and other diseases of diastolic dysfunction, which is in Phase II clinical development. The Company is using its proprietary drug discovery platform to develop a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address a broad array of serious muscle disorders. Its platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue.

Webull offers Edgewise Therapeutics Inc stock information, including NASDAQ: EWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EWTX stock methods without spending real money on the virtual paper trading platform.